Ypsomed Holding AG (SWX:YPSN)
Switzerland · Delayed Price · Currency is CHF 345.80
+6.80 (2.01%)
Jun 4, 2026, 5:30 PM CET
Ypsomed Holding AG Income Statement
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 730.98 | 748.87 | 548.46 | 497.46 | 464.84 | |
Revenue Growth (YoY) | -2.39% | 36.54% | 10.25% | 7.02% | 15.16% |
Cost of Revenue | 416.38 | 456.8 | 328.93 | 356.87 | 351.02 |
Gross Profit | 314.61 | 292.07 | 219.53 | 140.59 | 113.82 |
Selling, General & Admin | 89.91 | 125.54 | 107.99 | 103.29 | 89.42 |
Research & Development | 40.02 | 33.55 | 30.48 | - | - |
Other Operating Expenses | -79.97 | 9.89 | -5.16 | -6 | -4.18 |
Operating Expenses | 49.96 | 168.98 | 133.31 | 97.29 | 85.24 |
Operating Income | 264.64 | 123.09 | 86.22 | 43.3 | 28.58 |
Interest Expense | -3.18 | -6.64 | -4.82 | -2.09 | -2.05 |
Interest & Investment Income | 0.63 | 0.11 | 0.16 | 0.02 | 0.09 |
Currency Exchange Gain (Loss) | -2.15 | -1.3 | 0.53 | -1.67 | -0.6 |
Other Non Operating Income (Expenses) | -0.41 | -0.7 | -0.22 | -0.22 | -0.22 |
EBT Excluding Unusual Items | 259.54 | 114.55 | 81.87 | 39.34 | 25.8 |
Impairment of Goodwill | -18.57 | -10.24 | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.26 |
Gain (Loss) on Sale of Assets | - | - | - | 17.29 | - |
Pretax Income | 240.97 | 104.31 | 81.87 | 56.64 | 25.54 |
Income Tax Expense | 19.04 | 16.81 | 3.51 | 5.36 | 2.44 |
Net Income | 221.93 | 87.5 | 78.37 | 51.28 | 23.11 |
Net Income to Common | 221.93 | 87.5 | 78.37 | 51.28 | 23.11 |
Net Income Growth | 153.62% | 11.66% | 52.84% | 121.92% | 297.61% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 13 | 13 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 13 | 13 |
Shares Change (YoY) | -0.28% | 0.01% | 1.74% | 6.12% | 0.26% |
EPS (Basic) | 16.31 | 6.41 | 5.74 | 3.82 | 1.83 |
EPS (Diluted) | 16.30 | 6.41 | 5.74 | 3.82 | 1.83 |
EPS Growth | 154.29% | 11.67% | 50.26% | 109.06% | 296.58% |
Free Cash Flow | 11.18 | -57.4 | 46.85 | 30.65 | 34.11 |
Free Cash Flow Per Share | 0.82 | -4.20 | 3.43 | 2.28 | 2.70 |
Dividend Per Share | 4.400 | 2.200 | 2.000 | 1.300 | 0.600 |
Dividend Growth | 100.00% | 10.00% | 53.85% | 116.67% | -48.28% |
Gross Margin | 43.04% | 39.00% | 40.03% | 28.26% | 24.48% |
Operating Margin | 36.20% | 16.44% | 15.72% | 8.70% | 6.15% |
Profit Margin | 30.36% | 11.68% | 14.29% | 10.31% | 4.97% |
Free Cash Flow Margin | 1.53% | -7.66% | 8.54% | 6.16% | 7.34% |
EBITDA | 325.79 | 176.44 | 132.69 | 87.65 | 68.88 |
EBITDA Margin | 44.57% | 23.56% | 24.19% | 17.62% | 14.82% |
D&A For EBITDA | 61.15 | 53.35 | 46.47 | 44.35 | 40.3 |
EBIT | 264.64 | 123.09 | 86.22 | 43.3 | 28.58 |
EBIT Margin | 36.20% | 16.44% | 15.72% | 8.70% | 6.15% |
Effective Tax Rate | 7.90% | 16.11% | 4.28% | 9.47% | 9.53% |